Related references
Note: Only part of the references are listed.Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
Marco Tonello et al.
ANNALS OF SURGICAL ONCOLOGY (2022)
KRAS and BRAF Mutations in Stage II and III Colon Cancer: A Systematic Review and Meta-Analysis
Vincenzo Formica et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2022)
Association between microsatellite instability and tumor response to neoadjuvant chemoradiotherapy for rectal cancer
Soo Young Lee et al.
ANNALS OF SURGICAL TREATMENT AND RESEARCH (2022)
The prognostic value of KRAS mutation in locally advanced rectal cancer
Palash Asawa et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2022)
Targeting BRAF and RAS in Colorectal Cancer
Helene Bellio et al.
CANCERS (2021)
Relationship between mismatch repair protein, RAS, BRAF, PIK3CA gene expression and clinicopathological characteristics in elderly colorectal cancer patients
Jun-Zhen Fan et al.
WORLD JOURNAL OF CLINICAL CASES (2021)
Metabolic networks in mutant KRAS-driven tumours: tissue specificities and the microenvironment
Samuel A. Kerk et al.
NATURE REVIEWS CANCER (2021)
KRAS Codon 12 Mutation is Associated with More Aggressive Invasiveness in Synchronous Metastatic Colorectal Cancer (mCRC): Retrospective Research
Kang He et al.
ONCOTARGETS AND THERAPY (2020)
Prognostic Value of BRAF and KRAS Mutation in Relation to Colorectal Cancer Survival in Iranian Patients: Correlated to Microsatellite Instability
Ehsan Nazemalhosseini-Mojarad et al.
JOURNAL OF GASTROINTESTINAL CANCER (2020)
Relationships among KRAS mutation status, expression of RAS pathway signaling molecules, and clinicopathological features and prognosis of patients with colorectal cancer
Xiang-Bin Wan et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
G12V and G12C mutations in the gene KRAS are associated with a poorer prognosis in primary colorectal cancer
Tamuro Hayama et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2019)
Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence
Diamantis I. Tsilimigras et al.
SURGICAL ONCOLOGY-OXFORD (2018)
Prognostic Value of BRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer
Julien Taieb et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Prognostic Value of BRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer
Julien Taieb et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
KRAS, NRAS and BRAF mutations in colorectal cancer and melanoma
Jonas Cicenas et al.
MEDICAL ONCOLOGY (2017)
Prognostic value of KRAS codon 13 gene mutation for overall survival in colorectal cancer Direct and indirect comparison meta-analysis
Min Seob Kwak et al.
MEDICINE (2017)
Specific mutations in KRAS codon 12 are associated with worse overall survival in patients with advanced and recurrent colorectal cancer
Robert P. Jones et al.
BRITISH JOURNAL OF CANCER (2017)
Coexistence of MSI with KRAS mutation is associated with worse prognosis in colorectal cancer
Jing Hu et al.
MEDICINE (2016)
Colorectal carcinomas with KRAS codon 12 mutation are associated with more advanced tumor stages
Wenbin Li et al.
BMC CANCER (2015)
Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17
S. Y. Brule et al.
EUROPEAN JOURNAL OF CANCER (2015)
Low-Level Microsatellite Instability as a Potential Prognostic Factor in Sporadic Colorectal Cancer
Soo Young Lee et al.
MEDICINE (2015)
Association Between Specific Mutations in KRAS Codon 12 and Colorectal Liver Metastasis
Georgios Antonios Margonis et al.
JAMA SURGERY (2015)
Association between specific KRAS mutations and the clinicopathological characteristics of colorectal tumors
Hilmi Kodaz et al.
MOLECULAR AND CLINICAL ONCOLOGY (2015)
Clinical relevance of KRAS mutations in codon 13: Where are we?
Tze-Kiong Er et al.
CANCER LETTERS (2014)
The prognostic role of microsatellite instability, codon-specific KRAS, and BRAF mutations in colon cancer
Chun-Chi Lin et al.
JOURNAL OF SURGICAL ONCOLOGY (2014)
Analyses of clinicopathological, molecular, and prognostic associations of KRAS codon 61 and codon 146 mutations in colorectal cancer: cohort study and literature review
Yu Imamura et al.
MOLECULAR CANCER (2014)
Association between KRAS codon 13 mutations and clinical response to anti-EGFR treatment in patients with metastatic colorectal cancer: results from a meta-analysis
Jian Chen et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Colorectal carcinomas with KRAS mutation are associated with distinctive morphological and molecular features
Christophe Rosty et al.
MODERN PATHOLOGY (2013)
Specific Mutations in KRAS Codons 12 and 13, and Patient Prognosis in 1075 BRAF Wild-Type Colorectal Cancers
Yu Imamura et al.
CLINICAL CANCER RESEARCH (2012)
KRAS Mutation and Microsatellite Instability: Two Genetic Markers of Early Tumor Development That Influence the Prognosis of Colorectal Cancer
Garrett M. Nash et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Comparison of 17,641 Patients With Right- and Left-Sided Colon Cancer: Differences in Epidemiology, Perioperative Course, Histology, and Survival
Frank Benedix et al.
DISEASES OF THE COLON & RECTUM (2010)
Is there a difference in survival between right- versus left-sided colon cancers?
Robert A. Meguid et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer
A Lièvre et al.
CANCER RESEARCH (2006)
Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype
V Bazan et al.
ANNALS OF ONCOLOGY (2002)
Codon 12 and codon 13 mutations at the K-ras gene induce different soft tissue sarcoma types in nude mice
S Guerrero et al.
FASEB JOURNAL (2002)
Kirsten ras mutations in patients with colorectal cancer:: the 'RASCAL II' study
HJN Andreyev et al.
BRITISH JOURNAL OF CANCER (2001)
Share Paper
